Article Versions Notes

Theiler D, Cattaneo M, Dierickx LO, Igaz P, Grozinsky-Glasberg S, Bournaud C, O’Dorisio T, O’Dorisio MS, Wild D, Christ E, et al. Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients. Cancers. 2021; 13(24):6290. https://doi.org/10.3390/cancers13246290

Theiler, Deborah, Marco Cattaneo, Lawrence O. Dierickx, Peter Igaz, Simona Grozinsky-Glasberg, Claire Bournaud, Thomas O’Dorisio, M. Sue O’Dorisio, Damian Wild, Emanuel Christ, and et al. 2021. "Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients" Cancers 13, no. 24: 6290. https://doi.org/10.3390/cancers13246290

Theiler, D., Cattaneo, M., Dierickx, L. O., Igaz, P., Grozinsky-Glasberg, S., Bournaud, C., O’Dorisio, T., O’Dorisio, M. S., Wild, D., Christ, E., & Nicolas, G. P. (2021). Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients. Cancers, 13(24), 6290. https://doi.org/10.3390/cancers13246290